stimulants_med ep1
Name
thyroid_med
Label
Thyroid Medication: Self-reported use
Description

Self reported drugs at PSG visit, open text then grouped according to effect

Domain
takingornot
  • 0: Not taking
  • 1: Taking
Type
choices
Thyroid Medication: Self-reported use vs Study visit number
Visit 1 Visit 2 Visit 3 Visit 4 Visit 5
Total 1,123 758 566 121 2
Not taking 1,026 668 490 108 1
Taking 97 90 76 13 1
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 1
Male Female Total
Total 608 515 1,123
Not taking 579 447 1,026
Taking 29 68 97
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 2
Male Female Total
Total 406 352 758
Not taking 377 291 668
Taking 29 61 90
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 3
Male Female Total
Total 304 262 566
Not taking 280 210 490
Taking 24 52 76
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 4
Male Female Total
Total 67 54 121
Not taking 64 44 108
Taking 3 10 13
Thyroid Medication: Self-reported use vs Sex of the participant
Visit 5
Male Female Total
Total - 2 2
Not taking - 1 1
Taking - 1 1
Thyroid Medication: Self-reported use vs Race of the participant
Visit 1
White Black Hispanic Native American Asian Total
Total 1,065 23 13 10 12 1,123
Not taking 974 20 12 10 10 1,026
Taking 91 3 1 - 2 97
Thyroid Medication: Self-reported use vs Race of the participant
Visit 2
White Black Hispanic Native American Asian Total
Total 734 8 6 6 4 758
Not taking 646 7 5 6 4 668
Taking 88 1 1 - - 90
Thyroid Medication: Self-reported use vs Race of the participant
Visit 3
White Black Hispanic Native American Asian Total
Total 549 4 5 4 4 566
Not taking 475 3 4 4 4 490
Taking 74 1 1 - - 76
Thyroid Medication: Self-reported use vs Race of the participant
Visit 4
White Black Hispanic Native American Asian Total
Total 113 1 2 2 3 121
Not taking 100 1 2 2 3 108
Taking 13 - - - - 13
Thyroid Medication: Self-reported use vs Race of the participant
Visit 5
White Black Hispanic Native American Asian Total
Total 2 - - - - 2
Not taking 1 - - - - 1
Taking 1 - - - - 1